Tuesday, August 4, 2020
Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts
This week in HemOnc News:
- Higher death rate seen in cancer patients with nosocomial COVID-19
Article: https://bit.ly/2XjRLDq
Source: https://bit.ly/3goLGgF Robotic renal surgery bests open partial nephrectomy
Article: https://bit.ly/2PhHS4M
Source: https://bit.ly/3gqXXBdLarge cohort study: Bevacizumab safe, effective for severe HHT bleeds
Article: https://bit.ly/2XpuZdj
Source: https://bit.ly/2BXHVQg
For more MDedge Podcasts, click this link: http://bit.ly/2CfnY52
Email the show: podcasts@mdedge.com
Follow Dr. David Henry on Twitter @DavidHenryMD
How to Listen
Podcast Participants
David Henry, MD, FACP, is a clinical professor of medicine at the University of Pennsylvania and vice chairman of the department of medicine at Pennsylvania Hospital in Philadelphia. He received his bachelor’s degree from Princeton University and his MD from the University of Pennsylvania, then completed his internship, residency, and fellowship at the Hospital of the University of Pennsylvania. After 2 years as an attending in the U.S. Air Force, he was drawn to practicing as a hem-onc because of the close patient contact and interaction, and his belief that, win or lose with each patient, one can always make a difference in their care and lives. Follow Dr. Henry on Twitter: @davidhenrymd. Dr. Henry reported being on the advisory board for Amgen, AMAG Pharmaceuticals, and Pharmacosmos. He reported institutional funding from the National Institutes of Health and FibroGen.